Sacubitril And Valsartan Tablet, Film Coated
Product Images NDC 72603-880

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Sacubitril And Valsartan (NDC 72603-880). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

956 (Sacubitril Valsartan 24 mg 26 mg 180 Baddi)

Sacubitril and Valsartan Tablets 24 mg/26 mg film-coated tablet label, containing 180 tablets. The label includes dosage information, storage instructions, and manufacturer details. Manufactured by Macleods Pharmaceuticals Ltd., India, for NorthStar Rx LLC. Features a distinctive blue and white color scheme with dosage strength highlighted in a purple box.*

FDA Label Image

541 (Sacubitril Valsartan 24 mg 26 mg 180 Indore)

Sacubitril and Valsartan Tablets 24 mg/26 mg film-coated tablet label from NorthStar Rx LLC. The bottle contains 180 tablets. Storage instructions, barcode, manufacturing information by Macleods Pharmaceuticals Ltd, and product origin (India) are visible.*

FDA Label Image

879 (Sacubitril Valsartan 24 mg 26 mg 60 Baddi)

Label for Sacubitril and Valsartan Tablets 24 mg/26 mg film-coated tablets by NorthStar RxLLC. The label includes storage instructions, manufacturer details, and package size of 60 tablets. The label states it is prescription-only and includes a barcode and regulatory information.*

FDA Label Image

546 (Sacubitril Valsartan 24 mg 26 mg 60 Indore)

Label for Sacubitril and Valsartan Tablets 24 mg/26 mg, film-coated oral tablets. The label indicates a package containing 60 tablets manufactured by NorthStar Rx LLC and Macleods Pharmaceuticals Ltd. Storage instructions and other details including batch and expiration information are also present.*

FDA Label Image

856 (Sacubitril Valsartan 49 mg 51 mg 180 Baddi)

Label for Sacubitril and Valsartan Tablets, 49 mg/51 mg strength, film-coated oral tablets. The label shows a count of 180 tablets and indicates the product is Rx only. It is manufactured for NorthStar Rx LLC and by Macleods Pharmaceuticals Ltd, India. Storage instructions and barcode are also visible.*

FDA Label Image

985 (Sacubitril Valsartan 49 mg 51 mg 180 Indore)

Label for Sacubitril and Valsartan Tablets 49 mg/51 mg film-coated tablets, containing 180 tablets per container. The label includes storage instructions, manufacturer NorthStar Rx LLC, and manufacturing by Macleods Pharmaceuticals Ltd. in India. The product is for oral use and prescription only.*

FDA Label Image

520 (Sacubitril Valsartan 49 mg 51 mg 60 Baddi)

Packaging label for Sacubitril and Valsartan Tablets, 49 mg/51 mg strength, film-coated tablets. The label indicates a package count of 60 tablets. The product is manufactured for NorthStar Rx LLC in Memphis, TN, and by Macleods Pharmaceuticals Ltd. in India. Storage instructions and dosage information are partially visible, along with barcodes and regulatory information.*

FDA Label Image

336 (Sacubitril Valsartan 49 mg 51 mg 60 Indore)

Label for Sacubitril and Valsartan Tablets 49 mg/51 mg film-coated tablets. The package contains 60 tablets. The label includes storage instructions and manufacturer information, showing NorthStar Rx LLC and Macleods Pharmaceuticals Ltd. as manufacturers. The product is indicated as prescription only with a visible NDC 72603-881-01 barcode.*

FDA Label Image

564 (Sacubitril Valsartan 97 mg 103 mg 180 Baddi)

Label for Sacubitril and Valsartan Tablets 97 mg/103 mg film-coated tablets, 180 count, manufactured by Macleods Pharmaceuticals Ltd and labeled for NorthStar Rx LLC. The label includes storage instructions, barcode, and product origin information.*

FDA Label Image

848 (Sacubitril Valsartan 97 mg 103 mg 180 Indore)

Label for Sacubitril and Valsartan Tablets 97 mg/103 mg film-coated oral tablets by NorthStar Rx LLC. The label states a package size of 180 tablets and includes storage instructions, manufacturing details for NorthStar Rx LLC and Macleods Pharmaceuticals Ltd., and two barcodes. The label indicates the NDC number as 72603-882-02.*

FDA Label Image

123 (Sacubitril Valsartan 97 mg 103 mg 60 Baddi)

Label for Sacubitril and Valsartan Tablets 97 mg/103 mg by NorthStar Rx LLC. The label indicates the film-coated tablets come in a 60-count package. The label includes storage instructions, a barcode, manufacturing details from Macleods Pharmaceuticals Ltd. in India, and notes this is a prescription-only medication.*

FDA Label Image

456 (Sacubitril Valsartan 97 mg 103 mg 60 Indore)

Label for Sacubitril and Valsartan Tablets, 97 mg/103 mg film-coated oral tablets. The package contains 60 tablets. Labeler is NorthStar Rx LLC and the manufacturer is Macleods Pharmaceuticals Ltd. Dosage and storage instructions are partially visible, indicating prescription use only.*

FDA Label Image

778 (Sacubitril Valsartan Figure 1)

A forest plot chart showing the geometric mean ratio and 90% confidence interval of pharmacokinetic parameters AUC and Cmax for LB0657 and Valsartan. The chart compares changes relative to reference across different population groups including renal impairment levels, hepatic impairment levels, age groups, sex, and race/ethnicity.*

FDA Label Image

232 (Sacubitril Valsartan Figure 2)

A chart showing geometric mean ratios and 90% confidence intervals for AUC and Cmax comparing populations with renal or hepatic impairment, age, sex, and race groups relative to a reference. The chart contrasts values for LB0657 and Valsartan, indicating pharmacokinetic changes in different population subgroups.*

FDA Label Image

414 (Sacubitril Valsartan Figure 3a)

A Kaplan-Meier curve chart comparing the time to first occurrence of cardiovascular death or heart failure hospitalizations between Sacubitril and Valsartan and Enalapril in the PARADIGM-HF study. The graph shows cumulative failure rates over time in days, with sample sizes at risk noted below the x-axis. Sacubitril and Valsartan demonstrate a lower cumulative failure rate compared to Enalapril.*

FDA Label Image

654 (Sacubitril Valsartan Figure 3b)

A Kaplan-Meier curve graph titled 'Time to Occurrence of CV Death in PARADIGM-HF' showing cumulative failure rate (%) over time in days since randomization for two groups: Sacubitril and valsartan and Enalapril. It includes hazard ratio (HR) with 95% confidence interval. The graph plots lower failure rate for Sacubitril and valsartan compared to Enalapril, with patient numbers at risk listed at various time points below the x-axis.*

FDA Label Image

456 (Sacubitril Valsartan Figure 4)

A forest plot depicting hazard ratios with 95% confidence intervals comparing Sacubitril and Valsartan versus Enalapril across various subgroups defined by age, gender, weight, race, region, NYHA class, estimated GFR, diabetes status, blood pressure, ejection fraction, atrial fibrillation, NT-proBNP levels, hypertension, prior drug use, hospitalization, time since diagnosis, cause of heart failure, and presence of ICD devices. The plot includes subgroup sizes, percentage of total population, and event rates for both treatments.*

FDA Label Image

478 (Sacubitril Valsartan Figure 5)

A line chart titled 'Total Heart Failure Hospitalization and CV Death in PARAGON-HF' depicts the mean number of events per 100 patients over time since randomization in days. Two lines represent patients treated with Sacubitril and Valsartan versus Valsartan alone. The chart includes counts of patients at risk at various time points up to 1440 days.*

FDA Label Image

456 (Sacubitril Valsartan Figure 6)

A forest plot comparing Sacubitril and Valsartan versus Valsartan alone across various subgroups including age, gender, race, region, and clinical characteristics. The plot shows rate ratios with confidence intervals for each subgroup, indicating comparative treatment effects visually on a horizontal axis ranging from 0.25 to 2, where values less than 1 favor Sacubitril and Valsartan and values greater than 1 favor Valsartan.*

FDA Label Image

412 (Sacubitril Valsartan Figure 7)

A dual-panel line graph depicting hazard ratios with 95% confidence intervals for Sacubitril and Valsartan compared to enalapril (left panel) and to valsartan (right panel), plotted against left ventricular ejection fraction (%) at screening. The left panel is labeled PARADIGM-HF and the right panel PARAGON-HF.*

FDA Label Image

Str (Sacubitril Valsartan Str)

Chemical structure of the active ingredients Sacubitril and Valsartan, showing their molecular composition and arrangement, including aromatic rings and functional groups typical of these compounds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.